recent transactionshistorical transactions

Luitpold Pharmaceuticals, Inc.
Buy-side representation on the acquisition of a fully integrated specialty injectable pharmaceutical company

Closing: December 2009

Case Study    Press Release


Location: Shirley, NY
President and CEO: Mary Jane Helenek

- Buy-side representation of Luitpold in competitive process for the privately held PharmaForce.

- Aquilo worked closely both with US-based subsidiary Luitpold and with Tokyo-based parent company Daiichi Sankyo.

- PharmaForce focused on difficult to manufacture sterile products and sole source or first-to-market generic injectable products.